GlassScriptPhysician profile
Akanksha Saxena Murray
NPI 1063949238
$1,821.15
in general payments reported to CMS, 2019-2025
12 companies · $86.83 in 2025
The $86.83 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.57 · 2022: $1,392 · 2023: $221 · 2024: $105 · 2025: $86.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $1,148.94 | 2022 | |
| Abbvie INC. | $273.41 | 2022-2023 | |
| Hologic Sales and Service, LLC | $80.05 | 2022-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Medtronic, INC. | $78.68 | 2022-2024 | Interstim, Micra |
| Astellas Pharma US INC | $74.17 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $66.27 | 2023-2024 | |
| Myovant Sciences INC. | $21.04 | 2022 | |
| Pfizer INC. | $17.13 | 2023 | |
| Coopersurgical, INC. | $16.57 | 2021 | |
| Organon LLC | $15.79 | 2024 | |
| Sumitomo Pharma America, INC. | $14.68 | 2023 | Myfembree |
| Gilead Sciences, INC. | $14.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akanksha Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.